Skip to main content
. 2010 Apr;17(2):2–3. doi: 10.3747/co.v17i2.498

TABLE I.

Age group, comorbidities, use of granulocyte colony–stimulating factor (g-csf) and incidence of febrile neutropenia (fn)

Group Pts (n) fn rate
(%) Given (n) g-csf(%)
Age<65, no comorbidities 14 21 3 0
Age≥65 20 40 5 0
Comorbidities 12 58 4 0
Age≥65, comorbidities 7 71 2 0

Pts = patients.